Клинический случай муковисцидоза с развитием синдрома полиорганной недостаточности у ребенка
DOI:
https://doi.org/10.15574/SP.2017.85.132Ключевые слова:
муковисцидоз, дети, цирроз печени, синдром полиорганной недостаточностиАннотация
Представлен клинический случай муковисцидоза у ребенка, который был носителем тяжелой мутации гена муковисцидоза delF508 и умер от развития синдрома полиорганной недостаточности в возрасте 17 лет.
Библиографические ссылки
Kapranov NI, Kashirskaya NU. (2014). Cystic fibrosis. Medpractice: 672.
Manovitskaya NV, Borodina GL, Voytko TA. (2013). Dynamics of clinical status of adult patients with mucoviscidosis in the Republic of Belarus. health and environmental problems. 2(36): 29-35.
Krasovskiy SA, Samoylenko VA, Babadznova GU, Nagorniy BA. (2013). Cystic fibrosis and diabetes. Pulmonology and Allergology. 2: 32-36.
Kapranov NI, Kashirskaya NU, kusova ZA, Shelepneva ZA. (2010). The defeat of the pancreas in cystic fibrosis. Experimental and Clinical Gastroenterology. 8: 98-103.
Rogovik NV. (2013). The metabolism of vitamin E in cystic fibrosis. Pediatrics, Obstetrics and Gynecology. 76(3): 25-30.
Burgel P-R, Bellis G. (2015). Accuracy of modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry. Journal of Cystic Fibrosis. 14: 33. https://doi.org/10.1016/S1569-1993(15)30105-3
Ali BR. (2009). Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells? Med. Hypotheses. 72(1): 55-57. https://doi.org/10.1016/j.mehy.2008.07.058; PMid:18851900
Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. (2011). Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis. 10(2): 29-36. https://doi.org/10.1016/S1569-1993(11)60006-4
Flass T, Narkewicz MR. (2013). Cirrhosis and other liver disease in cystic fibrosis. Journal of Cystic Fibrosis. 12(2): 116-124. https://doi.org/10.1016/j.jcf.2012.11.010; PMid:23266093 PMCid:PMC3883947
Ebdon AM, Nolan S, Carr SB. (2014). Continuous glucose monitoring is a useful tool for diagnosis of cystic fibrosis related diabetes. Journal of Cystic Fibrosis. 13(13): 120. https://doi.org/10.1016/S1569-1993(14)60042-4
Flume PA, Peter J. Mogayzel PJ, Robinson KA, Goss CH, Rosenblat RL, Kuhn RJ, Marshall BC. (2009). Cystic Fibrosis Pulmonary Guidelines. American journal of respiratory and critical care medicine. 180: 802-808. https://doi.org/10.1164/rccm.200812-1845PP; PMid:19729669
Minicucci L. (2012). New diagnostic and therapeutic approaches in cystic fibrosis related diabetes (CFRD). Journal of Cystic Fibrosis. 7(6): 67-73.
Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M. (2013). Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test. Journal of Cystic Fibrosis. 13(1): 80-85. https://doi.org/10.1016/j.jcf.2013.06.001; PMid:23809507
Burgess JC, Bridges NY, Simmonds NJ. (2012). Using HbAlc and random blood glucose to screen for cystic fibrosis related diabetes (CFRD) Journal of Cystic Fibrosis. 11(116): 56. https://doi.org/10.1016/S1569-1993(12)60404-4
